Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance

Go back to Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance
(NASDAQ: TARS) Delayed: 61.80 -0.81 (1.29%)
Previous Close $62.61    52 Week High
Open $62.70    52 Week Low
Day High $63.61    P/E N/A 
Day Low $61.71    EPS
Volume 177,733